ES2163186T3 - Composicion que comprende mupirocina y clorhexidina. - Google Patents

Composicion que comprende mupirocina y clorhexidina.

Info

Publication number
ES2163186T3
ES2163186T3 ES97934558T ES97934558T ES2163186T3 ES 2163186 T3 ES2163186 T3 ES 2163186T3 ES 97934558 T ES97934558 T ES 97934558T ES 97934558 T ES97934558 T ES 97934558T ES 2163186 T3 ES2163186 T3 ES 2163186T3
Authority
ES
Spain
Prior art keywords
mupirocine
chlorhexidine
composition
useful
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97934558T
Other languages
English (en)
Inventor
Monica Lucie Drogemoller
Stanley Leslie Linley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Pharmaceuticals Pty Ltd
Original Assignee
SmithKline Beecham Pharmaceuticals Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Pharmaceuticals Pty Ltd filed Critical SmithKline Beecham Pharmaceuticals Pty Ltd
Application granted granted Critical
Publication of ES2163186T3 publication Critical patent/ES2163186T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES QUE CONTIENEN MUPIROCINA Y CLORHEXIDINA, LAS CUALES SON UTILES EN EL TRATAMIENTO DE INFECCIONES BACTERIANAS LOCALES, PARTICULARMENTE HERIDAS POR QUEMADURAS INFECTADAS.
ES97934558T 1996-08-01 1997-07-29 Composicion que comprende mupirocina y clorhexidina. Expired - Lifetime ES2163186T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9616208.6A GB9616208D0 (en) 1996-08-01 1996-08-01 Novel Compounds

Publications (1)

Publication Number Publication Date
ES2163186T3 true ES2163186T3 (es) 2002-01-16

Family

ID=10797878

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97934558T Expired - Lifetime ES2163186T3 (es) 1996-08-01 1997-07-29 Composicion que comprende mupirocina y clorhexidina.

Country Status (21)

Country Link
US (1) US6214866B1 (es)
EP (1) EP0921791B1 (es)
JP (1) JP2000517294A (es)
KR (1) KR20000029678A (es)
CN (1) CN1231606A (es)
AR (1) AR008797A1 (es)
AT (1) ATE207350T1 (es)
AU (1) AU708688B2 (es)
BR (1) BR9710899A (es)
CA (1) CA2262430A1 (es)
CZ (1) CZ29199A3 (es)
DE (1) DE69707691T2 (es)
ES (1) ES2163186T3 (es)
GB (1) GB9616208D0 (es)
IL (1) IL128317A (es)
NO (1) NO990440D0 (es)
NZ (1) NZ333896A (es)
PL (1) PL331423A1 (es)
TR (1) TR199900211T2 (es)
WO (1) WO1998005313A1 (es)
ZA (1) ZA976791B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
CA2546019A1 (en) * 2003-11-17 2005-06-02 Braintree Laboratories, Inc. Therapeutic peg solution concentrate
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060051384A1 (en) 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US8476319B2 (en) * 2005-03-10 2013-07-02 3M Innovative Properties Company Methods of treating ear infections
CN101175474B (zh) * 2005-03-10 2011-09-07 3M创新有限公司 降低微生物污染的方法
US9826770B2 (en) * 2005-03-10 2017-11-28 3M Innovative Properties Company Antimicrobial compositions comprising esters of hydroxycarboxylic acids
EP2091324B1 (en) 2006-10-27 2016-12-28 3M Innovative Properties Company Antimicrobial compositions
US20110097372A1 (en) * 2009-10-26 2011-04-28 Rucinski Paul J Devices, methods, and compositions for controlling infections
SE533425C2 (sv) * 2008-07-07 2010-09-21 Ambria Dermatology Ab Antimikrobiell sammansättning
JP2013508457A (ja) * 2009-10-26 2013-03-07 イノベーション テクノロジーズ インコーポレーティッド 感染を制御するための装置、方法、および組成物
DE102012215511A1 (de) 2012-08-31 2014-06-12 Schülke & Mayr GmbH Verfahren zur Herstellung einer Bispyridiniumalkan enthaltenden halbfesten Zubereitung
WO2017095352A1 (en) 2015-12-01 2017-06-08 Ataturk Universitesi Bilimsel Arastirma Projeleri Birimi Use of wax, olive oil, butter mixture and/ or its combination with varying ratios of boron and/ or derivatives thereof, in treatment of wounds, burns, and skin diseases
TWI738774B (zh) * 2016-05-06 2021-09-11 美商沙希公司 眼用組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758686A (en) 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
US4122158A (en) 1976-09-23 1978-10-24 Alza Corporation Topical therapeutic preparations
CA1196284A (en) 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
EP0128228B1 (de) 1983-06-08 1988-01-07 Ibm Deutschland Gmbh Verfahren und Anordnung zur Erzeugung von Impulsen beliebiger Zeitrelation innerhalb unmittelbar aufeinanderfolgender Impulsintervalle mit sehr hoher Genauigkeit und zeitlicher Auflösung
GB8415579D0 (en) 1984-06-19 1984-07-25 Beecham Group Plc Compounds
IT1202193B (it) 1985-10-31 1989-02-02 Pico Glass Spa Cornice porta-immagine
GB8530796D0 (en) 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US4847068A (en) 1987-08-06 1989-07-11 Johnson & Johnson Consumer Products, Inc. Skin care compositions
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment

Also Published As

Publication number Publication date
JP2000517294A (ja) 2000-12-26
ATE207350T1 (de) 2001-11-15
AR008797A1 (es) 2000-02-23
DE69707691D1 (de) 2001-11-29
ZA976791B (en) 1999-02-09
PL331423A1 (en) 1999-07-19
EP0921791B1 (en) 2001-10-24
WO1998005313A1 (en) 1998-02-12
CA2262430A1 (en) 1998-02-12
AU708688B2 (en) 1999-08-12
NO990440L (no) 1999-01-29
NZ333896A (en) 2000-06-23
DE69707691T2 (de) 2002-08-01
IL128317A (en) 2001-08-08
AU3771797A (en) 1998-02-25
CN1231606A (zh) 1999-10-13
KR20000029678A (ko) 2000-05-25
NO990440D0 (no) 1999-01-29
TR199900211T2 (xx) 1999-03-22
GB9616208D0 (en) 1996-09-11
EP0921791A1 (en) 1999-06-16
IL128317A0 (en) 2000-01-31
CZ29199A3 (cs) 1999-07-14
US6214866B1 (en) 2001-04-10
BR9710899A (pt) 2000-01-11

Similar Documents

Publication Publication Date Title
ES2163186T3 (es) Composicion que comprende mupirocina y clorhexidina.
BR9900320A (pt) Composição antimicrobiana
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
HUP9900962A2 (hu) Fertőtlenítőkészítmények és eljárások felületek fertőtlenítésére
UY25330A1 (es) Nuevos macrólidos
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
PE20001112A1 (es) Derivados de quinolina como agentes antibacterianos
AR031975A1 (es) Compuestos analogos de (1r,cis)-4-(6-amino-9h-purin-9-il) -2-ciclopenteno-1-metanol, proceso para su preparacion, su uso en el tratamiento de infecciones virales, y envase que los contiene
ATE287707T1 (de) Injizierbare propofol-formulierungen
DE60332101D1 (de) Antimikrobielle zusammensetzung
BR9408188A (pt) Composição de policlopreno
BR0315139A (pt) Agentes antibacterianos de tetraidroquinolina tricìclica
PT925789E (pt) Es oculares utilizacao de azitromicina no tratamento topico de infecco
PT1077718E (pt) Melhoramentos da actividade de agentes antibacterianos de oxazolidinona por derivados de arginina
ES2174921T3 (es) Inhibidores de la proteasa del vih.
BR9507437A (pt) Base livre de halofantrina e composições para o tratamento da malária
ATE229269T1 (de) Ektoparasitizide mittel
AR013411A1 (es) Composicion de aplicacion para tratamientos antivirales y afecciones micosicas y/o bacterianas y utilizacion de dichas composiciones.
ES2175356T3 (es) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares.
NO20010140L (no) Kjemotakse-inhiberende protein av Staphylococcus (CHIPS) og dets anvendelse
BR0108562A (pt) Composições endoparasiticidas
BR0311479A (pt) Derivados de tiofeno antelmìnticos e inseticidas
CO4410328A1 (es) Compuestos que son derivados de los antibioticos macrolidos rosaramicina, repromicina, 5-micaminosiltilonolida, desmico- sina, lactenocina, o-desmetil-lactenocina, cirramicina a1, y 23-desoximicaminosiltilonolida
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
GT199600072A (es) Formas zwitterionicas de trovafloxacina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 921791

Country of ref document: ES